Big Pharma on Aussie hiring spree
In a breath of fresh air for the Australian industry - which has been hit hard by years of workforce downsizing across multiple companies - this Big Pharma is on a hiring spree
In a breath of fresh air for the Australian industry - which has been hit hard by years of workforce downsizing across multiple companies - this Big Pharma is on a hiring spree
Potential best-in-class therapy and first anticancer treatment to be administered via an on-body injector could be heading Down Under
The TGA has approved a new presentation of this company's RSV jab as it seeks to expand its reach in a competitive market by targeting a younger cohort
Redundancies, restructures and tighter headcounts have triggered a shift away from traditional linear career progression via promotions to more "sideways moves"
Company confirms it has decided to discontinue a long-standing cancer drug from the Australian market on the same day as its anaemia therapy due to an evolving treatment landscape
Senior leader named as Director of Policy and External Engagement just as the industry body heads into crucial Strategic Agreement negotiations
A new collaboration will work on the development of a treatment involving gene therapy for a condition that affects 10-20 per cent of middle-aged Australians
On the 7.30 Report this week Dave Ricks made it clear he was not interested in accepting a low-ball price to have the company's blockbuster drug listed on the PBS
Doctors have lifted the lid on what they really want when it comes to medical information, with non-pharma companies ready to disrupt industry's relationship with HCPs
A survey of specialists including Aussie clinicians reveals that where treatments look clinically similar, the emotional connection a brand builds separates it from the rest
Brides-to-be have one more thing to worry about: they’re losing so much weight on GLP-1 drugs that their dresses no longer fit
On a sabbatical year, this well-known industry executive has entered the Australian Portrait Artist of the Year Competition, painting Dannii Minogue
Company ordered to face trial over allegations it defrauded investors by withholding information about a clinical trial for a next-gen drug
With 10 prescription medicine applications on the TGA's review list, this pharma is at the forefront of bringing new therapies to Australia
Who's nabbed the former Health Minister as a Non-Executive Director to advise on medicines policy and support the company's growth?